Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
₹28.0 L
EMD Value
Exempted
Closing Date
18 Jun 2024, 3:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Procurement of Various Medicines
6450444
GEM/2024/B/4987351
Two Packet Bid
Cefuroxime inj 750 mg,Cetrizine plus Ambroxyl Syp 100 ml,Imipenam plus Cilastatin Inj 1 gm,Paraceta
365 days
Madhya Pradesh; Bhopal
Item wise evaluation
BOQ
7 documents required · 7 mandatory
Exempted
18 Jun 2024
28 May 2024
18 Jun 2024
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Cefuroxime inj 750 mg | Cefuroxime inj 750 | 9,000 | pieces | santoshtiwari@123 | 365 |
| 2 | Cetrizine plus Ambroxyl Syp 100 ml | Cetrizine and Ambroxol Syp | 37,000 | pieces | santoshtiwari@123 | 365 |
| 3 | Imipenam plus Cilastatin Inj 1 gm | Imipenam and Cilastatin Inj 1 gm | 200 | pieces | santoshtiwari@123 | 365 |
| 4 | Paracetamol Inj 1 percent 100 ml | Paracetamol Inj 1 percent 100 ml | 20,000 | pieces | santoshtiwari@123 | 365 |
| 5 | Sucralfate Syp 200 ml | Sucralfate Syp 200 ml | 15,000 | pieces | santoshtiwari@123 | 365 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6450444.pdf
GEM_BID
terms_and_conditions_2024-05-27-17-29-14_7efae6cf342b03576cc15bd51e5cca9c.pdf
BOQ
boq_2024-05-27-17-29-14_b3bcf67093f1833096edf4a556d3d8b6.csv
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .